news
Dronabinol reduces PTSD nightmares in new trial
A new study in Nature Medicine found that dronabinol, a synthetic cannabinoid, significantly reduced nightmare frequency in 74 adults with PTSD. Participants receiving 2.5–20 mg of dronabinol nightly saw a 74% reduction in nightmare days. This offers a new option for a condition that really messes with sleep architecture.
A new study in Nature Medicine found that dronabinol, a synthetic cannabinoid, significantly reduced nightmare frequency in 74 adults with PTSD. Participants receiving 2.5–20 mg of dronabinol nightly saw a 74% reduction in nightmare days. This offers a new option for a condition that really messes with sleep architecture.
The architecture take
I've heard people swear by cannabis for sleep, especially to blunt those super vivid, unsettling dreams. This study finally gives some proper data to back that up for PTSD. It’s not just about a clearer head during the day; nightmare reduction is a huge win for anyone battling PTSD because sleep disruption is a major player in that whole cycle of anxiety and hypervigilance. Dronabinol taps into the endocannabinoid system, which helps regulate mood, sleep, and memory processing. Less REM-sleep disturbance means a more regulated nervous system overall. It's a precise application of a compound many already use anecdotally. Watch for more targeted cannabinoid research, especially around sleep and trauma — the FDA won't move on cannabis, but pharmaceutical cannabinoids are a different story.